PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.\', \'Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA.\', \'BIOQUAL Inc., Rockville, Maryland, USA.\', \'Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.\', \'Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA.\', \'Alchem Laboratories Corporation, Alachua, Florida, USA.\', \'Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/jci.insight.148494148494
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 33908897
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all